We compared the serum IGF-1 and IGFBP-3 levels, as well as the IGF-1/IGFBP-3 ratio, between the hypsarrhythmia and non-hypsarrhythmia groups before ACTH treatment. This evidence concerns the gene IGF1 and Hypsarrhythmia.